These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 7557093

  • 1. Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function.
    Albillos A, Lledó JL, Rossi I, Pérez-Páramo M, Tabuenca MJ, Bañares R, Iborra J, Garrido A, Escartín P, Bosch J.
    Gastroenterology; 1995 Oct; 109(4):1257-65. PubMed ID: 7557093
    [Abstract] [Full Text] [Related]

  • 2. Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension.
    Albillos A, García-Pagán JC, Iborra J, Bandi JC, Cacho G, Pérez-Paramo M, Escorsell A, Calleja JL, Escartín P, Bosch J.
    Gastroenterology; 1998 Jul; 115(1):116-23. PubMed ID: 9649466
    [Abstract] [Full Text] [Related]

  • 3. Hemodynamic effects of alpha-adrenergic blockade with prazosin in cirrhotic patients with portal hypertension.
    Albillos A, Lledó JL, Bañares R, Rossi I, Iborra J, Calleja JL, Garrido A, Escartin P, Bosch J.
    Hepatology; 1994 Sep; 20(3):611-7. PubMed ID: 7915703
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis.
    Lee WC, Lin HC, Yang YY, Hou MC, Lee FY, Chang FY, Lee SD.
    Am J Gastroenterol; 2001 Apr; 96(4):1210-6. PubMed ID: 11316172
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of Sapropterin on Portal and Systemic Hemodynamics in Patients With Cirrhosis and Portal Hypertension: A Bicentric Double-Blind Placebo-Controlled Study.
    Reverter E, Mesonero F, Seijo S, Martínez J, Abraldes JG, Peñas B, Berzigotti A, Deulofeu R, Bosch J, Albillos A, García-Pagán JC.
    Am J Gastroenterol; 2015 Jul; 110(7):985-92. PubMed ID: 26077176
    [Abstract] [Full Text] [Related]

  • 8. Effects of captopril on renal functions, renal and portal hemodynamics in patients with cirrhosis.
    Tsai YT, Lin HC, Lee FY, Hou MC, Wang SS, Lee SD.
    Proc Natl Sci Counc Repub China B; 1996 Apr; 20(2):44-50. PubMed ID: 8931343
    [Abstract] [Full Text] [Related]

  • 9. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
    Narahara Y, Kanazawa H, Taki Y, Kimura Y, Atsukawa M, Katakura T, Kidokoro H, Harimoto H, Fukuda T, Matsushita Y, Nakatsuka K, Sakamoto C.
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1791-7. PubMed ID: 19686420
    [Abstract] [Full Text] [Related]

  • 10. Effects of verapamil on hepatic and systemic hemodynamics and liver function in patients with cirrhosis and portal hypertension.
    Navasa M, Bosch J, Reichen J, Bru C, Mastai R, Zysset T, Silva G, Chesta J, Rodés J.
    Hepatology; 1988 Nov; 8(4):850-4. PubMed ID: 3391511
    [Abstract] [Full Text] [Related]

  • 11. Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: long-term hemodynamic and renal effects.
    Morillas RM, Planas R, Cabré E, Galán A, Quer JC, Feu F, García Pagán JC, Bosch J, Gassull MA.
    Hepatology; 1994 Dec; 20(6):1502-8. PubMed ID: 7982651
    [Abstract] [Full Text] [Related]

  • 12. The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites.
    Kalambokis G, Economou M, Kosta P, Papadimitriou K, Tsianos EV.
    J Clin Gastroenterol; 2006 Apr; 40(4):342-6. PubMed ID: 16633107
    [Abstract] [Full Text] [Related]

  • 13. Effects of terlipressin on hemodynamics and oxygen content in conscious portal vein stenosed and cirrhotic rats receiving propranolol.
    Lebrec D, Moreau R, Cailmail S, Sogni P, Oberti F, Hadengue A.
    J Hepatol; 1993 Jan; 17(1):102-7. PubMed ID: 8445208
    [Abstract] [Full Text] [Related]

  • 14. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Abraldes JG, Albillos A, Bañares R, Turnes J, González R, García-Pagán JC, Bosch J.
    Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study.
    García-Pagán JC, Feu F, Bosch J, Rodés J.
    Ann Intern Med; 1991 May 15; 114(10):869-73. PubMed ID: 2014947
    [Abstract] [Full Text] [Related]

  • 19. A randomized study of losartan vs propranolol: Effects on hepatic and systemic hemodynamics in cirrhotic patients.
    Castaño G, Viudez P, Riccitelli M, Sookoian S.
    Ann Hepatol; 2003 May 15; 2(1):36-40. PubMed ID: 15094704
    [Abstract] [Full Text] [Related]

  • 20. Selective and non-selective beta receptor blockade in the reduction of portal pressure in patients with cirrhosis and portal hypertension.
    Westaby D, Bihari DJ, Gimson AE, Crossley IR, Williams R.
    Gut; 1984 Feb 15; 25(2):121-4. PubMed ID: 6693039
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.